Diagnosis and Management of Oral Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 01 2022
01 01 2022
Historique:
pubmed:
25
9
2021
medline:
26
2
2022
entrez:
24
9
2021
Statut:
ppublish
Résumé
Inflammatory bowel diseases (IBD) represent a group of chronic inflammatory disorders of the gastrointestinal tract that lead to impaired quality of life and substantial health care costs. Up to 50% of pediatric IBD cases present with manifestations in the oral cavity. These may develop in nearly every oral tissue, including the soft tissues, tongue, lips, teeth, and lymph nodes. The goal of this review is to offer a systematic approach to diagnose and manage commonly encountered oral manifestations of pediatric IBD. This knowledge is critical for enhancing the comprehensive care and quality of life of children with these debilitating diseases.
Identifiants
pubmed: 34560727
doi: 10.1097/MPG.0000000000003302
pii: 00005176-202201000-00002
pmc: PMC8714692
mid: NIHMS1740606
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-12Subventions
Organisme : NIDCR NIH HHS
ID : K08 DE026537
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034987
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK122042
Pays : United States
Informations de copyright
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors report no conflicts of interest.
Références
Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5:17–30.
Loftus EV Jr. Update on the incidence and prevalence of inflammatory bowel disease in the United States. Gastroenterol Hepatol (NY) 2016; 12:704–707.
Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr 2015; 169:1053–1060.
Pittock S, Drumm B, Fleming P, et al. The oral cavity in Crohn's disease. J Pediatr 2001; 138:767–771.
Skrzat A, Olczak-Kowalczyk D, Turska-Szybka A. Crohn's disease should be considered in children with inflammatory oral lesions. Acta Paediatr 2017; 106:199–203.
Lee JS, Somerman MJ. The importance of oral health in comprehensive health care. JAMA 2018; 320:339–340.
Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol 2005; 3:886–891.
Plauth M, Jenss H, Meyle J. Oral manifestations of Crohn's disease. An analysis of 79 cases. J Clin Gastroenterol 1991; 13:29–37.
Tremblay L, de Chambrun GP, De Vroey B, et al. Stevens–Johnson syndrome with sulfasalazine treatment: report of two cases. J Crohns Colitis 2011; 5:457–460.
Yuan A, Woo S-B. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119:35–47.
Bissonnette C, Kauzman A, Mainville GN. Oral pyoderma gangrenosum: diagnosis, treatment and challenges: a systematic review. Head Neck Pathol 2017; 11:427–441.
Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am 2014; 58:281–297.
Mawardi H, Alsubhi A, Salem N, et al. Management of medication-induced gingival hyperplasia: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2021; 131:62–72.
Koutsochristou V, Zellos A, Dimakou K, et al. Dental caries and periodontal disease in children and adolescents with inflammatory bowel disease: a case–control study. Inflamm Bowel Dis 2015; 21:1839–1846.
Malins TJ, Wilson A, Ward-Booth RP. Recurrent buccal space abscesses: a complication of Crohn's disease. Oral Surg Oral Med Oral Pathol 1991; 72:19–21.
Furness S, Worthington HV, Bryan G, et al. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev 2011. CD008934doi: 10.1002/14651858.CD008934.pub2.
doi: 10.1002/14651858.CD008934.pub2
Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Therap Clin Risk Manage 2014; 11:45–51.
Boirivant M, Cossu A. Inflammatory bowel disease. Oral Dis 2012; 18:1–15.
Katsanos KH, Torres J, Roda G, et al. Non-malignant oral manifestations in inflammatory bowel diseases. Aliment Pharmacol Ther 2015; 42:40–60.
Sanderson J, Nunes C, Escudier M, et al. Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease? Inflamm Bowel Dis 2005; 11:840–846.
Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis—a 20-year review. Oral Dis 2009; 15:46–51.
Brocklehurst P, Tickle M, Glenny AM, et al. Systemic interventions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database Syst Rev 2012. CD005411doi: 10.1002/14651858.CD005411.pub2.
doi: 10.1002/14651858.CD005411.pub2
Femiano F, Lanza A, Buonaiuto C, et al. Pyostomatitis vegetans: a review of the literature. Med Oral Patol Oral Cir Bucal 2009; 14:E114–E117.
Neville BW, Smith SE, Maize JC, et al. Pyostomatitis vegetans. Am J Dermatopathol 1985; 7:69–77.
Woo S-B. Oral Pathology: A Comprehensive Atlas and Text/Sook-Bin Woo. Philadelphia, PA: Elsevier; 2017.
Mantegazza C, Angiero F, Zuccotti GV. Oral manifestations of gastrointestinal diseases in children. Part 3. Ulcerative colitis and gastro-oesophageal reflux disease. Eur J Paediatr Dent 2016; 17:248–250.
Asarch A, Gottlieb AB, Lee J, et al. Lichen planus–like eruptions: an emerging side effect of tumor necrosis factor-α antagonists. J Am Acad Dermatol 2009; 61:104–111.
Kuten-Shorrer M, Hochberg EP, Woo S-B. Lichenoid mucosal reaction to rituximab. Oncologist 2014; 19:e12–e13.
Salama M, Lawrance IC. Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's disease. World J Gastroenterol 2009; 15:4449.
Deeming GM, Collingwood J, Pemberton MN. Methotrexate and oral ulceration. Br Dent J 2005; 198:83–85.
Asarch A, Gottlieb AB, Lee J, et al. Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 2009; 61:104–111.
Fernández-González F, Vázquez-Álvarez R, Reboiras-López D, et al. Histopathological findings in oral lichen planus and their correlation with the clinical manifestations. Med Oral Patol Oral Cir Bucal 2011; 16:e641–e646.
Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: (Suppl): S25.e21-12.
Yang H, Wu Y, Ma H, et al. Possible alternative therapies for oral lichen planus cases refractory to steroid therapies. Oral Surg Oral Med Oral Pathol Oral Radiol 2016; 121:496–509.
Wee JS, Shirlaw PJ, Challacombe SJ, et al. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. Br J Dermatol 2012; 167:36–43.
Deeming GMJ, Collingwood J, Pemberton MN. Methotrexate and oral ulceration. Br Dental J 2005; 198:83–85.
Howland WW, Golitz LE, Weston WL, et al. Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol 1984; 10:438–446.
Wetter DA, Davis MDP. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic 2000 to 2007. J Am Acad Dermatol 2010; 62:45–53.
Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993; 128:542–545.
Gutierrez Gossweiler A, Martinez-Mier EA. Chapter 6: Vitamins and oral health. Monogr Oral Sci 2020; 28:59–67.
Rahman N, Walls A. Chapter 12: Nutrient deficiencies and oral health. Monogr Oral Sci 2020; 28:114–124.
Lalla RV, Patton LL, Dongari-Bagtzoglou A. Oral candidiasis: pathogenesis, clinical presentation, diagnosis and treatment strategies. J Calif Dent Assoc 2013; 41:263–268.
Vagianos K, Bector S, McConnell J, et al. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007; 31:311–319.
Lynch RJM, Duckworth RM. Chapter 4: Microelements. Part I: Zn, Sn, Cu, Fe and I. Monogr Oral Sci 2020; 28:32–47.
Krasinski SD, Russell RM, Furie BC, et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr 1985; 41:639–643.